Key Findings:  This study evaluated the blood concnetnrations of 18 cannabinoids within 24 hours of cannabis consumption. All except CBDA and CBLA were detected in at least one analyzed sample. As expected the concentration of minor cannabinoids was low. There was no correlation between the blood concentration and the interval between consumption and blood sampling.
Type of Study:  Clinical Trial
Study Sample Size:  117
Study Result:  Positive
Study Location(s):  Germany
Year of Pub:  2021
Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabichromenic Acid (CBC-a), Cannabidiolic Acid (CBD-a), Cannabigerolic Acid (CBG-a), Tetrahydrocannabinolic Acid (THC-a), Cannabinoid (unspecified), Tetrahydrocannabivarin (THCV), Delta-8-THC, Cannabidivarin (CBDV)
Phytocannabinoid Source:  Not Applicable